BisphosphonateFDA-approvedAdjuvant
Zolendronate
How it works
Blocks the action of osteoclasts, cells that break down bone tissue. This can help reduce bone pain and fractures in cancer patients.
Cancer types
Efficacy
Studies have shown that zolendronate can reduce the risk of skeletal events in ovarian cancer patients.
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Zoledronic Acid Linked to Rare Kidney Disorder in Cancer Patients | Prostate Cancer | observational | — | Source → |
| Copper Complex Kills Leukemia Cells in Lab Experiments | Leukemia | lab-study | — | Source → |
| Understanding Resistance to Zoledronic Acid in Breast Cancer Cells | Breast Cancer | lab-study | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.